AMGN Today - Aug 10: Guggenheim Raises Price Target
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Here’s what happened. Amgen had a pretty chill day, with trading volume right in line with its average. No big swings or wild moves. It’s like everyone was just sitting back, sipping their coffee, and waiting for something to happen.
Now, why the slow day? Well, there’s a mix of stuff going on. Guggenheim just raised their price target for Amgen to $388, thanks to a strong quarter. That’s a good sign, but it seems like investors are still processing all the news from the past week. Amgen jumped about 8% earlier this week after they raised their guidance, which got folks excited. But then, Erste Group Bank came in and lowered their earnings estimates, which kinda threw a wet blanket on the party. So, it’s a bit of good news and bad news swirling around. Nobody really knows why it didn’t pop today, but sometimes the market just does its own thing.
Looking ahead, there’s chatter about Amgen’s pipeline updates. They’re working on some promising stuff that could shake things up in the future. So, that’s something to keep an eye on.
Alright, that’s a wrap for today’s Amgen scoop! Just remember, I’m here for the info and good vibes, not to give financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません